Benjamin Cravatt III
From Wikipedia, the free encyclopedia
| Benjamin F Cravatt | |
 |
|
| Fields | Chemical Biology |
|---|---|
| Institutions | The Scripps Research Institute ActivX Biosciences |
| Known for | Proteomics |
Benjamin Franklin Cravatt is a professor in the Departments of Cell Biology and Chemistry at The Scripps Research Institute in La Jolla, California. Considered the inventor of activity based proteomics,[who?] he is a prominent figure in the nascent field of chemical biology. He has made contributions to the cannabinoid field, most notably, identification and characterization of the endocannabinoid-terminating enzyme fatty acid amide hydrolase, FAAH, as well as the isolation of the novel soporific compound oleamide from cerebrospinal fluid [1][2].
Cravatt is a Cope and Searle Scholar, and the co-founder of ActivX Biosciences.
[edit] See also
[edit] External links
[edit] References
- ^ Cravatt B.F., Giang D.K., Mayfield S.P., Boger D.L., Lerner, R.A.; "Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides"; Nature 384:83 (1996). PMID 8900284
- ^ Cravatt BF, Prospero-Garcia O, Siuzdak G, Gilula NB, Henriksen SJ, Boger DL, Lerner RA. Chemical characterization of a family of brain lipids that induce sleep. Science. 1995 268(5216):1506-9. PMID 7770779
 |
This article about an American businessperson is a stub. You can help Wikipedia by expanding it. |
 This article about a U.S. scientist is a stub. You can help Wikipedia by expanding it. |
